A small study found MS patients reported improved quality of life and reduced depression after Ocrelizumab biosimilar ...
Multiple sclerosis is a disease in which the immune system erroneously attacks a protective insulation that surrounds neurons ...
MONDAY, Nov. 10, 2025 (HealthDay News) — Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million people estimated to be living with ...
Get all latest & breaking news on Multiple Sclerosis. Watch videos, top stories and articles on Multiple Sclerosis at moneycontrol.com.
The Canadian biotechnology firm Bionxt Solutions has reported encouraging preclinical results for its proprietary drug delivery system. The company’s oral thin film (ODF) formulation of Cladribin, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results